A phase I study of doxorubicin in horses with advanced tumors.

被引：0
|
作者：
Theon, A. P. [1 ]
Magdesian, G. K. [1 ]
Pusterla, N. [1 ]
Wilson, W. D. [1 ]
机构：
[1] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA
来源：
JOURNAL OF VETERINARY INTERNAL MEDICINE | 2007年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
345
引用
收藏
页码：667 / 667
页数：1
相关论文
共 50 条
  • [41] Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors
    Eng, C
    Mauer, AM
    Fleming, GF
    Bertucci, D
    Rotmensch, J
    Jacobs, RH
    Ratain, MJ
    ANNALS OF ONCOLOGY, 2001, 12 (12) : 1743 - 1747
  • [42] Phase I study of pazopanib and ixabepilone in patients with solid tumors.
    Ganesan, Chitra
    Obulareddy, J.
    Bliss, Robin L.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2013, 73 (08)
  • [43] A phase I study of ARRY-520 in solid tumors.
    Goncalves, P. H.
    Sausville, E. A.
    Edelman, M. J.
    Pandya, N. B.
    Houlehan, M. M.
    Freeman, B.
    Simmons, H. M.
    Stallings, J. S.
    Ptaszynski, A. M.
    LoRusso, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [45] Results of phase I clinical trials of Coramsine in patients with advanced solid tumors.
    Millward, M.
    Powell, A.
    Daly, P.
    Tyson, S.
    Ferguson, R.
    Carter, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [46] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [47] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [48] A phase I dose escalation and pharmacodynamic study of weekly administered AlbuleukinTM in patients with advanced solid tumors.
    Agarwala, SS
    Bukowski, RM
    Kirkwood, J
    Weiss, P
    Olencki, T
    Grzegorewski, KJ
    Melder, R
    Fox, RA
    Herpst, JM
    Gallant, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6230S - 6231S
  • [49] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345